Chemistry:Butolame
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | 17β-((4-Hydroxybutyl)amino)estradiol; 17β-[(4-Hydroxybutyl)amino]estra-1,3,5(10)-trien-3-ol |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C22H33NO2 |
| Molar mass | 343.511 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Butolame, also known as 17β-((4-hydroxybutyl)amino)estradiol, is a synthetic, steroidal estrogen and a 17β-aminoestrogen with anticoagulant effects that was first described in 1993 and was never marketed.[1][2][3]
References
- ↑ Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. 2001. p. 2352. ISBN 978-3-527-30247-5. https://books.google.com/books?id=zmpqAAAAMAAJ.
- ↑ "Anticoagulant and estrogenic effects of two new 17 beta-aminoestrogens, butolame [17 beta-(4-hydroxy-1-butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17 beta-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol]". Steroids 58 (10): 457–461. October 1993. doi:10.1016/0039-128x(93)90002-5. PMID 8256254.
- ↑ "In vivo estrogen bioactivities and in vitro estrogen receptor binding and transcriptional activities of anticoagulant synthetic 17beta-aminoestrogens". The Journal of Steroid Biochemistry and Molecular Biology 73 (1–2): 59–66. May 2000. doi:10.1016/s0960-0760(00)00053-4. PMID 10822025.
 |  |
